BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35271889)

  • 1. A screening strategy for identifying the dominant variant of SARS-COV-2 in the fifth peak of Kurdistan- Iran population using HRM and Probe-based RT-PCR assay.
    Moradzad M; Soltani H; Salehi H; Rahmani K; Khateri D; Rahimi MZ; Az D; Fakhari S
    J Virol Methods; 2022 Jun; 304():114514. PubMed ID: 35271889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid screening assay for L452R and T478K spike mutations in SARS-CoV-2 Delta variant using high-resolution melting analysis.
    Aoki A; Adachi H; Mori Y; Ito M; Sato K; Okuda K; Sakakibara T; Okamoto Y; Jinno H
    J Toxicol Sci; 2021; 46(10):471-476. PubMed ID: 34602531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
    Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
    Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Strategy for the Detection of SARS-CoV-2 Variants Based on Multiplex PCR-Mass Spectrometry Minisequencing Technology.
    Zhao F; Lu J; Lu B; Qin T; Wang X; Hou X; Meng F; Xu X; Li T; Zhou H; Zhang J; Kan B; Huang Y; Zhang Z; Xiao D
    Microbiol Spectr; 2021 Dec; 9(3):e0126721. PubMed ID: 34787499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.
    Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H
    Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of SARS-CoV-2 and the L452R spike mutation using reverse transcription loop-mediated isothermal amplification plus bioluminescent assay in real-time (RT-LAMP-BART).
    Iijima T; Ando S; Kanamori D; Kuroda K; Nomura T; Tisi L; Kilgore PE; Percy N; Kohase H; Hayakawa S; Seki M; Hoshino T
    PLoS One; 2022; 17(3):e0265748. PubMed ID: 35312732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Rapid and Accessible Reverse Transcription-Quantitative PCR Approach for SARS-CoV-2 Variant of Concern Identification.
    Yeung PS; Wang H; Sibai M; Solis D; Yamamoto F; Iwai N; Jiang B; Hammond N; Truong B; Bihon S; Santos S; Mar M; Mai C; Mfuh KO; Miller JA; Huang C; Sahoo MK; Zehnder JL; Pinsky BA
    J Clin Microbiol; 2022 May; 60(5):e0017822. PubMed ID: 35465708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Analytical and Clinical Performance and Usefulness in a Real-Life Hospital Setting of Two in-House Real-Time RT-PCR Assays to Track SARS-CoV-2 Variants of Concern.
    Moisan A; Soares A; De Oliveira F; Alessandri-Gradt E; Lecoquierre F; Fourneaux S; Plantier JC; Gueudin M
    Viruses; 2023 May; 15(5):. PubMed ID: 37243201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of SARS-CoV-2 spike protein D614G mutation by qPCR-HRM analysis.
    Gazali FM; Nuhamunada M; Nabilla R; Supriyati E; Hakim MS; Arguni E; Daniwijaya EW; Nuryastuti T; Haryana SM; Wibawa T; Wijayanti N
    Heliyon; 2021 Sep; 7(9):e07936. PubMed ID: 34514180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of SARS-CoV-2 and techniques of diagnosis and surveillance.
    Ishige T
    Adv Clin Chem; 2024; 118():35-85. PubMed ID: 38280807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion.
    Augusto G; Mohsen MO; Zinkhan S; Liu X; Vogel M; Bachmann MF
    Allergy; 2022 Jan; 77(1):111-117. PubMed ID: 34453338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and qualitative identification of SARS-CoV-2 mutations associated with variants of concern using a multiplex RT-PCR assay coupled with melting analysis.
    Sberna G; Fabeni L; Berno G; Carletti F; Specchiarello E; Colavita F; Meschi S; Matusali G; Garbuglia AR; Bordi L; Lalle E
    Int J Infect Dis; 2022 Sep; 122():401-404. PubMed ID: 35760381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared Mutations in Emerging SARS-CoV-2 Circulating Variants May Lead to Reverse Transcription-PCR (RT-PCR)-Based Misidentification of B.1.351 and P.1 Variants of Concern.
    Losada C; Rico-Luna C; Otero-Sobrino Á; Molero-Salinas A; Buenestado-Serrano S; Candela A; Pérez-Lago L; Muñoz P; Catalán P; de Viedma DG;
    Microbiol Spectr; 2021 Oct; 9(2):e0081621. PubMed ID: 34643437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
    Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
    mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A one-step real-time RT-PCR assay for simultaneous typing of SARS-CoV-2 mutations associated with the E484K and N501Y spike protein amino-acid substitutions.
    Chaintoutis SC; Chassalevris T; Tsiolas G; Balaska S; Vlatakis I; Mouchtaropoulou E; Siarkou VI; Tychala A; Koutsioulis D; Skoura L; Argiriou A; Dovas CI
    J Virol Methods; 2021 Oct; 296():114242. PubMed ID: 34274369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RT-qPCR Assays for Rapid Detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 Mutations: A Screening Strategy to Identify Variants With Clinical Impact.
    Vega-Magaña N; Sánchez-Sánchez R; Hernández-Bello J; Venancio-Landeros AA; Peña-Rodríguez M; Vega-Zepeda RA; Galindo-Ornelas B; Díaz-Sánchez M; García-Chagollán M; Macedo-Ojeda G; García-González OP; Muñoz-Valle JF
    Front Cell Infect Microbiol; 2021; 11():672562. PubMed ID: 34123874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex SARS-CoV-2 Genotyping Reverse Transcriptase PCR for Population-Level Variant Screening and Epidemiologic Surveillance.
    Wang H; Miller JA; Verghese M; Sibai M; Solis D; Mfuh KO; Jiang B; Iwai N; Mar M; Huang C; Yamamoto F; Sahoo MK; Zehnder J; Pinsky BA
    J Clin Microbiol; 2021 Jul; 59(8):e0085921. PubMed ID: 34037430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified high-resolution melting-based assay (HRM) to identify the SARS-CoV-2 N501Y variant.
    Aoki A; Adachi H; Mori Y; Ito M; Sato K; Kinoshita M; Kuriki M; Okuda K; Sakakibara T; Okamoto Y; Jinno H
    J Virol Methods; 2023 Apr; 314():114678. PubMed ID: 36681163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying SARS-CoV-2 Variants of Concern through Saliva-Based RT-qPCR by Targeting Recurrent Mutation Sites.
    Ham RE; Smothers AR; Che R; Sell KJ; Peng CA; Dean D
    Microbiol Spectr; 2022 Jun; 10(3):e0079722. PubMed ID: 35546574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.